| Literature DB >> 31956052 |
Daniele Zendrini Rechenchoski1, Karoline Fontana Agostinho2, Ligia Carla Faccin-Galhardi2, Audrey Alesandra Stinghen Garcia Lonni3, João Vinícius Honório da Silva4, Fábio Goulart de Andrade4, Arcelina Pacheco Cunha5, Nágila Maria Pontes Silva Ricardo5, Carlos Nozawa2, Rosa Elisa Carvalho Linhares6.
Abstract
Mangiferin is found in many plant species as the mango tree (Mangifera indica) with ethnopharmacological applications and scientific evidence. The emergence of resistant herpes simplex virus (HSV) strains to Acyclovir (ACV) has encouraged the search for new drugs. We investigated the in vitro and in vivo activity of mangiferin obtained from M. indica against ACV-resistant HSV-1 (AR-29) and sensitive (KOS) strains. The in vitro activity was performed under varying treatment protocols. The substance showed a CC50 > 500 μg/mL and IC50 of 2.9 μg/mL and 3.5 μg/mL, respectively, for the AR-29 and KOS strains. The in vivo activity was performed in Balb/c mice treated with 0.7% topical mangiferin formulation. This formulation inhibited most effectively the AR-29 strain, attenuated the lesions, postponed their appearance or enhanced healing, in comparison to control group. We demonstrated the potentiality of mangiferin from M. indica to control HSV replication with emphasis to ACV-resistant infection.Entities:
Keywords: Acyclovir-Resistance; Antiviral; HSV; Mangifera indica; Mangiferin
Mesh:
Substances:
Year: 2020 PMID: 31956052 DOI: 10.1016/j.bmc.2020.115304
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641